查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712741

2025年全球製藥微生物檢測套組市場報告

Pharma Microbiology Testing Kits Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年醫藥微生物檢測套組的市場規模將快速成長。到 2029 年，這一數字將成長至 107.8 億美元，複合年成長率為 10.4%。預測期內的成長可歸因於藥物微生物學檢測中自動化應用的增加、藥物微生物學檢測研發投資的增加、藥物微生物學檢測、生物製藥製造和個人化醫療中新技術的應用增加。預測期內的主要趨勢包括快速微生物學檢測、就地檢驗、一次性系統、數位整合以及生物安全和生物安保。

全球感染疾病激增推動了醫藥微生物檢測套組市場的發展。正如疾病預防控制中心所強調的，甲型肝炎、B型肝炎、C型肝炎、性病和愛滋病毒等疾病正在增加。 2021年，世界衛生組織的報告指出，全球每年約有140萬例甲型肝炎。感染針頭注射、無保護的性行為、無家可歸以及醫療保健機會有限等因素導致感染疾病病例增加，從而推動了對製藥微生物檢測套組的需求。

預計醫療保健支出的增加將推動製藥微生物學檢測套組市場的發展。醫療保健支出包括個人、組織和政府在特定時期內用於醫療保健相關商品和服務的總支出。醫療保健支出的增加將導致對藥物微生物學檢測套組的需求增加。因為醫療機構投資了全面的感染控制措施。因此，將更頻繁地進行微生物污染物和病原體的檢測，以確保患者安全並符合監管標準。例如，2023年11月，總部位於加拿大的非營利組織加拿大衛生資訊研究所預測，2023年醫療保健總支出將達到3,440億美元，與前一年同期比較小幅增加2.8%。因此，醫療保健成本的增加將推動製藥微生物學檢測套組市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球製藥微生物檢測套組PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球製藥微生物檢測套組市場：成長率分析
  • 全球製藥微生物檢測套組市場表現：規模與成長，2019-2024
  • 全球製藥微生物檢測套組市場預測：規模與成長，2024-2029 年，2034 年
  • 製藥微生物檢測套組的全球總目標市場（TAM）

第6章市場區隔

  • 全球製藥微生物檢測套組市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 裝置
  • 全球製藥微生物檢測套組市場，測試、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 內毒素檢測
  • 無菌測試
  • 微生物學
  • 環境監測
  • 其他測試
  • 全球製藥微生物檢測套組市場（按最終用戶、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 醫院和診斷中心
  • 自訂化驗服務提供商
  • 學術研究所
  • 全球製藥微生物檢測套組市場按耗材類型、性能及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 培養基和試劑
  • 檢測套組
  • 樣本收集容器
  • 全球製藥微生物檢測套組市場，按設備、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 培養箱
  • 高壓釜
  • 微生物鑑定系統

第7章 區域和國家分析

  • 全球製藥微生物檢測套組市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球製藥微生物檢測套組市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 製藥微生物檢測套組市場：競爭格局
  • 製藥微生物檢測套組市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • SGS SA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Toxikon Corp.
  • Pace Analytical Services
  • Boston Analytics
  • Charles River Laboratories International
  • Nelson Laboratories
  • Siemens Healthcare AG
  • Hologic Inc.
  • Neogen Corporation
  • Shimadzu Corporation
  • Merck KGaA
  • Agilent Technologies Inc.
  • QIAGEN NV
  • Bruker Corporation
  • bioMerieux SA
  • Lucideon

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年製藥微生物檢測套組市場：哪些國家將帶來新機會
  • 2029年製藥微生物檢測套組市場：細分市場帶來新機會
  • 2029年製藥微生物檢測套組市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32952

Pharma microbiology testing kits play a critical role in identifying contamination and maintaining high standards in pharmaceuticals. These kits are instrumental in detecting microbial limits in drugs, vaccines, and other biologics.

The primary products within pharma microbiology testing kits include consumables and equipment. Consumables are used specifically for detecting microbial limits in pharmaceutical products. These kits facilitate various tests such as endotoxin testing, sterility testing, microbial examination, environmental monitoring, among others. These testing procedures cater to end-users such as hospitals, diagnostic centers, custom lab service providers, academic institutions, and research institutes.

The pharma microbiology testing kits market research report is one of a series of new reports from The Business Research Company that provides pharma microbiology testing kits market statistics, including pharma microbiology testing kits industry global market size, regional shares, competitors with a pharma microbiology testing kits market share, detailed pharma microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the pharma microbiology testing kits industry. This pharma microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma microbiology testing kits market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing demand for pharmaceuticals, increasing prevalence of infectious diseases, rising globalization, rising awareness of the importance of pharma microbiology testing, globalization of pharmaceutical production.

The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $10.78 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing use of automation in pharma microbiology testing, rising investment in pharma microbiology testing research and development, growing adoption of new technologies in pharma microbiology testing, biopharmaceutical manufacturing, personalized medicine. Major trends in the forecast period include rapid microbial testing, point-of-care testing, single-use systems, digital integration, biosafety and biosecurity.

The pharma microbiology testing kits market is being propelled by the surge in infectious diseases globally. Diseases like Hepatitis A, B, and C, STDs, and HIV are on the rise, as highlighted by the CDC. In 2021, The WHO report noted approximately 1.4 million annual cases of Hepatitis A worldwide. Factors such as infected needle injections, unprotected sex, homelessness, and limited medical access contribute to the escalating instances of infectious diseases, thereby driving the demand for pharma microbiology testing kits.

The rising healthcare expenditure is expected to advance the pharma microbiology testing kits market. Healthcare expenditure encompasses the total amount spent by individuals, organizations, or governments on healthcare-related goods and services over a specific period. An increase in healthcare spending leads to a higher demand for pharma microbiology testing kits, as healthcare facilities invest in comprehensive infection control measures. This results in more frequent testing for microbial contaminants and pathogens to ensure patient safety and compliance with regulatory standards. For instance, in November 2023, the Canadian Institute for Health Information, a nonprofit organization based in Canada, projected that total health expenditure would reach $344 billion in 2023, representing a modest growth of 2.8% compared to the previous year. Therefore, the increase in healthcare expenditure will drive growth in the pharma microbiology testing kits market.

Contracting out routine microbiological testing to specialized laboratories is gaining traction within the pharma microbiology testing kits market. This outsourcing strategy ensures stringent quality and safety standards for raw materials, intermediates, and end products. Contract testing labs manage various testing domains like stability testing, method validation, microbial testing, and batch-release testing. Notably, the global healthcare analytical testing market is projected to reach $4.13 billion by 2021, growing at an 11.3% rate, signaling the expanding reliance on outsourcing for such services.

Major companies in the pharma microbiology testing kits market are increasingly adopting innovative technologies, such as artificial intelligence (AI), to enhance operational efficiency. The use of AI to improve operational efficiency involves leveraging intelligent technologies to boost business performance, streamline processes, reduce costs, and facilitate better decision-making through automation and data analysis. For example, in May 2023, Becton, Dickinson, and Company, a medical device firm based in the U.S., received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new BD Kiestra MRSA Imaging Application. This application employs artificial intelligence to improve the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA). It automates the inspection of Petri dishes, a process that has traditionally been labor-intensive and time-consuming, by analyzing bacterial growth on BBL CHROMagar MRSA II plates. The application can swiftly identify specimens that exhibit no significant growth, thereby expediting the processing and release of negative results.

In November 2022, IDEXX, a healthcare innovation company based in the US, acquired Tecta-PDS for an undisclosed sum. This strategic acquisition aims to broaden IDEXX's presence in the field of water microbiology testing. Tecta-PDS, headquartered in Canada, specializes in water microbiology testing services.

Major companies operating in the pharma microbiology testing kits market include F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMerieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation

North America was the largest region in the pharma microbiology testing kits market in 2024. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the pharma microbiology testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Microbiology Testing Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma microbiology testing kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma microbiology testing kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma microbiology testing kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Consumables; Equipment
  • 2) By Test: Endotoxin Testing; Sterility Testing; Microbial Examination; Environmental Monitoring; Other Tests
  • 3) By End User: Hospitals & Diagnostic Centers; Custom Lab Service Providers; Academic & Research Institutes
  • Subsegments:
  • 1) By Consumables: Media and Reagents; Test Kits; Sample Collection Containers
  • 2) By Equipment: Incubators; Autoclaves; Microbial Identification Systems
  • Companies Mentioned: F. Hoffmann-La Roche AG; Becton Dickinson and Company; Abbott Laboratories; ThermoFisher Scientific; SGS SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma Microbiology Testing Kits Market Characteristics

3. Pharma Microbiology Testing Kits Market Trends And Strategies

4. Pharma Microbiology Testing Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharma Microbiology Testing Kits Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharma Microbiology Testing Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharma Microbiology Testing Kits Market Growth Rate Analysis
  • 5.4. Global Pharma Microbiology Testing Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharma Microbiology Testing Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharma Microbiology Testing Kits Total Addressable Market (TAM)

6. Pharma Microbiology Testing Kits Market Segmentation

  • 6.1. Global Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Equipment
  • 6.2. Global Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endotoxin Testing
  • Sterility Testing
  • Microbial Examination
  • Environmental Monitoring
  • Other Tests
  • 6.3. Global Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals & Diagnostic Centers
  • Custom Lab Service Providers
  • Academic & Research Institutes
  • 6.4. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Media and Reagents
  • Test Kits
  • Sample Collection Containers
  • 6.5. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Incubators
  • Autoclaves
  • Microbial Identification Systems

7. Pharma Microbiology Testing Kits Market Regional And Country Analysis

  • 7.1. Global Pharma Microbiology Testing Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharma Microbiology Testing Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma Microbiology Testing Kits Market

  • 8.1. Asia-Pacific Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma Microbiology Testing Kits Market

  • 9.1. China Pharma Microbiology Testing Kits Market Overview
  • 9.2. China Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma Microbiology Testing Kits Market

  • 10.1. India Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma Microbiology Testing Kits Market

  • 11.1. Japan Pharma Microbiology Testing Kits Market Overview
  • 11.2. Japan Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma Microbiology Testing Kits Market

  • 12.1. Australia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma Microbiology Testing Kits Market

  • 13.1. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma Microbiology Testing Kits Market

  • 14.1. South Korea Pharma Microbiology Testing Kits Market Overview
  • 14.2. South Korea Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma Microbiology Testing Kits Market

  • 15.1. Western Europe Pharma Microbiology Testing Kits Market Overview
  • 15.2. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma Microbiology Testing Kits Market

  • 16.1. UK Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma Microbiology Testing Kits Market

  • 17.1. Germany Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma Microbiology Testing Kits Market

  • 18.1. France Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma Microbiology Testing Kits Market

  • 19.1. Italy Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma Microbiology Testing Kits Market

  • 20.1. Spain Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma Microbiology Testing Kits Market

  • 21.1. Eastern Europe Pharma Microbiology Testing Kits Market Overview
  • 21.2. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma Microbiology Testing Kits Market

  • 22.1. Russia Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma Microbiology Testing Kits Market

  • 23.1. North America Pharma Microbiology Testing Kits Market Overview
  • 23.2. North America Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma Microbiology Testing Kits Market

  • 24.1. USA Pharma Microbiology Testing Kits Market Overview
  • 24.2. USA Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma Microbiology Testing Kits Market

  • 25.1. Canada Pharma Microbiology Testing Kits Market Overview
  • 25.2. Canada Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma Microbiology Testing Kits Market

  • 26.1. South America Pharma Microbiology Testing Kits Market Overview
  • 26.2. South America Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma Microbiology Testing Kits Market

  • 27.1. Brazil Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma Microbiology Testing Kits Market

  • 28.1. Middle East Pharma Microbiology Testing Kits Market Overview
  • 28.2. Middle East Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma Microbiology Testing Kits Market

  • 29.1. Africa Pharma Microbiology Testing Kits Market Overview
  • 29.2. Africa Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma Microbiology Testing Kits Market Competitive Landscape And Company Profiles

  • 30.1. Pharma Microbiology Testing Kits Market Competitive Landscape
  • 30.2. Pharma Microbiology Testing Kits Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Pharma Microbiology Testing Kits Market Other Major And Innovative Companies

  • 31.1. Toxikon Corp.
  • 31.2. Pace Analytical Services
  • 31.3. Boston Analytics
  • 31.4. Charles River Laboratories International
  • 31.5. Nelson Laboratories
  • 31.6. Siemens Healthcare AG
  • 31.7. Hologic Inc.
  • 31.8. Neogen Corporation
  • 31.9. Shimadzu Corporation
  • 31.10. Merck KGaA
  • 31.11. Agilent Technologies Inc.
  • 31.12. QIAGEN N.V.
  • 31.13. Bruker Corporation
  • 31.14. bioMerieux SA
  • 31.15. Lucideon

32. Global Pharma Microbiology Testing Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma Microbiology Testing Kits Market

34. Recent Developments In The Pharma Microbiology Testing Kits Market

35. Pharma Microbiology Testing Kits Market High Potential Countries, Segments and Strategies

  • 35.1 Pharma Microbiology Testing Kits Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharma Microbiology Testing Kits Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharma Microbiology Testing Kits Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer